MYC and JUN, well‐known proto‐oncogenes, promote tumor growth and induce drug resistance.[58, 59, 60] Our study revealed that ADAM10/NOTCH2 signaling promotes tumor growth and chemotherapy resistance by activating the transcription of MYC and JUN in CRC. Here, NOTCH2 is linked to colorectal carcinoma.